2021
Expanding Criteria for Prognostic Stage IA in Hormone Receptor–Positive Breast Cancer
Kantor O, King TA, Shak S, Russell CA, Giuliano AE, Hortobagyi GN, Burstein HJ, Winer EP, Dey T, Sparano JA, Mittendorf EA. Expanding Criteria for Prognostic Stage IA in Hormone Receptor–Positive Breast Cancer. Journal Of The National Cancer Institute 2021, 113: 1744-1750. PMID: 34010423, PMCID: PMC8634483, DOI: 10.1093/jnci/djab095.Peer-Reviewed Original ResearchConceptsDisease-specific survivalStage IA patientsStage IAIA patientsPrognostic stagingBreast cancerFive-year disease-specific survivalHormone receptor-positive breast cancerHER2-negative breast cancerReceptor-positive breast cancerN0-1 diseaseN0-1 patientsRecurrence Score resultsEnd Results (SEER) dataAmerican Joint CommitteeAJCC staging systemAJCC eighth editionT1-2N1Primary outcomePrognostic significanceStaging systemTNM categoriesT categoryRS resultsN category
2020
Expanding criteria for prognostic stage IA disease in HR+ breast cancer.
Kantor O, King T, Shak S, Russell C, Giuliano A, Hortobagyi G, Burstein H, Winer E, Sparano J, Mittendorf E. Expanding criteria for prognostic stage IA disease in HR+ breast cancer. Journal Of Clinical Oncology 2020, 38: 550-550. DOI: 10.1200/jco.2020.38.15_suppl.550.Peer-Reviewed Original ResearchStage IA diseaseRecurrence scoreIA diseaseN categoryOncotype DX recurrence scoreNode-positive diseaseAJCC staging systemDX recurrence scoreRS resultsRS 11Median followDSS ratesPositive diseaseSEER databaseReceptor statusStaging systemEvidence of utilityScore 11Breast cancerTrial dataDiseaseAdditional studiesPatientsStagingDSS